The Latest Breaking News from UBS

A study by Women in Banking and Finance and the London School of Economics focuses on finance professionals in the U.K.

The FDA just approved its most expensive drug ever — a hemophilia gene therapy from CSL and UniQure — and QURE stock popped Wednesday.

Marcus Margulies faced allegations that he had concealed funds from a “secret” trust held in a Swiss bank account.

Amid the ongoing macroeconomic and geopolitical issues, the stock market has faced wild swings this year. As the sky-high inflation and the Fed’s aggressive rate hikes continue to heighten recessionary fears, Wall Street darlings Microsoft (MSFT), Pfizer (PFE), and Coca-Cola (KO), which have a solid dividend-paying record, might be ideal…

With the macroeconomic headwinds putting pressure on business margins, the market volatility is not expected to ease anytime soon. With the midterm elections adding to the unpredictability, investors would be best served by seeking refuge in geographically diversified and robust businesses, Microsoft (MSFT) and Walmart (WMT). These stocks promise consistent…

On the surface stocks just seem to be trading calmly in a trading range. Under the surface things are setting up for continuation of the bear market which is why UBS now predicts market bottom around 3,200 for the S&P 500 (SPY). Get 40 year investment veteran, Steve Reitmeister’s, updated…

German officials have searched UBS bank branches in Frankfurt and Munich as part of an investigation into suspected money-laundering by a Russian oligarch Alisher Usmanov.

City Voices: Veteran traders have nothing but sympathy for Tom Hayes

In line with most expectations, the Fed has announced its fourth consecutive 75 bps interest rate hike today. However, since analysts don't expect the stock market volatility to ease in the near term, it could be safe to invest in fundamentally strong and high-quality stocks Microsoft (MSFT), Sprouts Farmers Market…